United States · FDA National Drug Code directory
NATEGLINIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-759_9ed1dbe4-49df-4d94-9e8b-3cdc081a3dd0
- Product NDC
- 16571-759
- Form
- TABLET
- Composition / generic term
- NATEGLINIDE
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201216
- Source listing expiry
- 20261231
Source-listed ingredients
- NATEGLINIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (16571-759-01) · 16571-759-01
- 90 TABLET in 1 BOTTLE (16571-759-09) · 16571-759-09
- 500 TABLET in 1 BOTTLE (16571-759-50) · 16571-759-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →